FDA Updates COVID-19 Test Policy; Shifts Focus From EUAs
Executive Summary
As part of a policy revamp, the US FDA is encouraging COVID-19 test developers to pursue traditional premarket review pathways rather than emergency use authorizations.
You may also be interested in...
Califf Sits Down For Fireside Chat; Looks Back And Ahead
Robert Califf marked his one-year anniversary as the commissioner of the US Food and Drug Administration by discussing the first year of his second term as the agency’s chief executive and his vision for the future.
CDRH 2022: Shuren Says COVID-19 Left Agency ‘Battle-Scarred’ But Also Wiser
The US Food and Drug Administration’s device center released its annual report, noting the challenges posed by monkeypox on top of the ongoing COVID-19 pandemic. The report also cites what the center sees as its accomplishments for the year.
FDA Grants EUA For Plant-Based Face Mask
A biodegradable plant-based face mask has won FDA approval for use in healthcare settings, combatting the high amounts of waste generated by pandemic precautions.